comprises materials and devices that can fulfill just this dual ionic-electronic capability. Iontronics utilize the coupling of electrical and ionic signals in conducing polymers, leading to, for example, organic electrochemical transistors (OECTs), [2] electrolyte-gated (also known as electric doublelayer capacitor-gated) organic field-effect transistors (EGOFETs), [3, 4] organic electrochemical biosensors, [5, 6] and iontronic delivery electrodes and devices. [7] [8] [9] [10] [11] In iontronic delivery devices (Figure 1) , chemical gradients are created by controlled release of charged biomolecules (ions) at specific locations at specific times. [7, 8, 12] Ions are transported to these release sites through ionic conductors due to applied electric fields between electrodes. The ionic conductors form the foundation of iontronic resistors (organic electronic ion pumps, OEIPs), diodes, and transistors which can be combined into circuits for, for example, multiplexing, addressing, and signal processing. These iontronic circuits behave analogous to traditional electronics, but use ions as charge carriers rather than electrons, and allow for the development of fully chemical systems generating complex signal patterns at high spatiotemporal resolution and biochemical specificity.
Introduction
Interfacing electronics with biological systems poses a technological hurdle, largely due to the fact that the vast majority of biological signaling is mediated by ions and molecules rather than electrons. Leveraging materials which allow electronic signals to manipulate and control gradients of ions and mole cules [1] provides a route to efficient interfaces that mimic biological communication. The branch of organic electronics known as "iontronics" proteins), and/or the ability to transport neutral substances (as opposed to ions). There are also promising combinations of systems such as microfluidic-based iontronics, [17] [18] [19] which combine features and restrictions of both fields. These other technologies are covered extensively in the literature; therefore, this Research News article will predominantly focus on electronic control over the transport and processing of ion signals through selective, ionically conducting materials.
Ionic Conduction
In the technologies presented in this article, controlled ionic conduction is achieved by applying an electric field over ion exchange membranes (IEMs), generally polymers with charged side groups. If the IEM is based on a polyanion (Figure 2a Iontronic components and applications. The basic OEIP structure for a) selective cation transport and b) selective anion transport. Ionic bipolar membrane diodes with c) lateral junction and d) stacked junction; zoom shows accumulation and depletion of the BM junction in forward and reverse bias. e) npn-IBJT in forward bias. f) pnp-IBJT with a neutral junction; zoom shows accumulation and depletion of the neutral junction in forward and reverse bias. g) Collection of iontronic components in applied systems, including from left to right the bioelectronic neural pixel, [36] fast vertical release devices, [31] and freestanding OEIPs. [16] Varying chemical stimulation gives varying cellular response that can be monitored externally or internally by, for example, optical read-out or electrical sensing. Please note that this figure is out of scale.
Polyelectrolyte CEMs and AEMs are analogous to p-and n-type semiconductors, in that the material will primarily conduct either positive or negative charge carriers. Selectivity toward cations or anions is based on the density of fixed charges in the membrane, and is defined by the transport number, with t equal to unity corresponding to 100% selectivity. [20] The ionic current through the membrane is then a combination of migration controlled by the electric field and diffusion along concentration gradient(s), with diffusion most noticeable when no potential is applied.
Electrophoretic transport of ions through an IEM provides a distinguishing characteristic of iontronics from other drug/ substance delivery technologies: transport is not flow-based; only ions are delivered to the target. When delivered, high concentrations of ions are accumulated at the release site-defined by the intersection of the ion transport channel (AEM or CEM) and the target electrolyte system-resulting in a steep concentration gradient. The delivered ions will then diffuse away from the outlet, affecting surrounding cells or tissue. Since delivery is based on diffusion away from the release site, computational modeling is an effective tool to determine concentrations at specific locations and times, and has been used to study basic [12, 21] and high-performance [22] delivery dynamics of neurotransmitters.
Materials
Iontronic components are based on two main parts: electrodes and IEMs. The most frequently used electrode material is the conducting polymer poly(3,4-ethylenedioxythiophene):poly-(styrene sulfonate) (PEDOT:PSS) (Figure 2a ). Several different IEM materials have been successfully used in iontronic components, first using linear polymers (Figure 2b ,c) and advancing into tailor-made hyperbranched (dendrolyte) materials [23] (Figure 2d ). The effective resistivity and selectivity are dependent on the size and configuration of the transported ionic species as well as the chemical and geometric microstructure of the IEM material. Generally, two key parameters determine an IEM's ionic transport performance: fixed charge density and effective pore size. Ionic conductivity scales linearly with the density of fixed charges, and a high density of fixed charges is necessary to achieve Donnan exclusion (i.e., cation or anion selectivity). Additionally, the effective pore size and distribution play important roles in determining a given ion's mobility in the hydrated IEM. To date, this trade-off points toward a balance of selectivity and mobility of metal ions and charged biomolecules less than ≈200 g mol −1 . [8, 23, 24] Linear IEM materials have been shown to be excellent conductors for small ions such as K + , Na aspartate (Asp), and acetylcholine (ACh) (Figure 2e ). The first generation of iontronic components used overoxidized PEDOT:PSS as the CEM. [7] Poly(styrene sulfonate)-co-maleic acid cross-linked with polyethylene glycol (PSS-co-MA/PEG) was later introduced as an alternative with higher fabrication flexibility and better selectivity. [25] The hydrogel polyanion poly(diallyldimethylammonium chloride) (pDADMAC) and polycation poly(2-acrylamido-2-methyl-1-propanesulfonic acid) (pAMPSA) have also been demonstrated in microfluidics-based iontronic circuits. [26] The AEMs poly(vinylbenzyl chloride) quaternized by dimethylbenzylamine (qPVBC) and poly(vinylbenzyl chloride) quaternized by triphenylphospine (PVBPPh 3 ) were introduced as complementary materials in diodes [27, 28] and transistors. [29, 30] Such linear IEMs have not yet demonstrated the ability to transport larger ions. For the transport of larger or more rigid compounds such as indoleacetic acid (IAA − , auxin), IEMs based on dendrolyte materials with large, well-defined porous structures have been investigated. [23] However, the development of IEM materials specifically for use in iontronic devices and applications remains limited and there is an opportunity for improvements in virtually all performance characteristics. Key goals for optimized or new IEM materials are: compatibility with printing and microfabrication techniques and materials, high ionic conductivity of larger and more rigid compounds in the ≈200-500 g mol −1 range, controlled swelling and structural stability while hydrated, and compatibility with substrate and packaging materials. Ultimately, the choice of IEM material for each device is not only dependent on the charge and configuration of the target biomolecule for delivery but also dependent on microfabrication techniques, preferred support substrate, and the form factor for the given application.
Iontronic Components

Resistors/OEIPs
The most basic, original [7] iontronic component is the OEIP (Figure 1a,b) . The core concept of an OEIP is to transport ions or molecules from a reservoir to a target system such as cells or tissue. Transport is accomplished by applying an electric field over an organic polymer membrane usually referred to as the OEIP channel, which divides the source reservoir and the target outlet, and mobile charged species are electrophoretically "pumped" toward the oppositely charged electrode.
The ionic current in OEIPs is proportional to the applied electric field and thus shows many conceptual similarities with traditional electrical resistors. Indeed, the IEM channel of an OEIP can be tailored based on an intrinsic ionic resistivity, leading to a geometry-dependent ionic resistance, precisely as with electrical resistivity and resistance. [10] The OEIP may thus be considered an iontronic resistor. The geometry of the channel depends on its application but tends to be planar, long, and narrow, leading to a high resistance, which limits the current passing through the device. However, this is an effective way to keep the diffusive "off-current" low.
The ionic current consists primarily of counterions (majority charge carriers) transported in the forward direction, but also of a small contribution from coions (minority charge carriers) in the reverse direction. An accurate assessment of dose control thus requires a measurement of the device's charge selectivity. The selectivity is estimated by measuring the delivered number of ions in the target electrolyte, after a known/measured amount of charge. This method can be complemented by membrane potential measurements, where different concentrations of electrolyte are separated by the membrane, and give rise to a potential that correlates with the apparent transport number. [25] Combining these methods, a high degree of precision regarding the quantity of delivered ions is achieved, directly dependent on the driving current (time-integrated current is equivalent to the total charge transported) and the IEM selectivity. The efficiency of delivery of zwitterionic neurotransmitters, such as GABA, will also depend on the pH of the source electrolyte. GABA undergoes morphological changes at different pH, which affects the transport properties. These effects have been investigated by measuring transport at different pH and combining the results with molecular dynamics simulations. For GABA, the optimal pH was calculated, and verified experimentally, to be at pH 3. [24] An interesting alternative to the basic architecture described above has been presented by Rolandi and co-workers. Inspired by the Grotthuss mechanism of H + transport through ice, they have developed a range of iontronic devices based on H + and OH − currents through hydrated biopolymers. [31, 32] These devices leverage PdH x electrodes, which act as a source or sink of H + (when the device is maintained in a H 2 -rich atmosphere), and thus represent a straightforward tool for investigating and characterizing purely protonic currents. The use of PdH x -based "protonics" is described in detail by Strakosas et al. [33] in their recent review article.
Diodes
Combinations of CEMs and AEMs lead to devices with nonlinear characteristics, for example, diodes and transistors, enabling more advanced signal control than with only resistorlike OEIPs. A two-layer stack containing a CEM and an AEM is called a bipolar membrane (BM), and shows current versus voltage characteristics similar to a p-n junction (Figure 1c,d ) [27, 34] The BM junction can also be considered as two OEIPs in series, with oppositely charged channels. In forward bias, the dominant charge carriers in both layers of the BM migrate toward the AEM/CEM junction in the middle, and are replenished by ions from the surrounding electrolytes, leading to the forward "on-current" between the electrolytes on either side of the BM. The change of polarity at the junction prevents ions from crossing into the oppositely charged layers, and the ions will thus accumulate at the junction. However, when the concentration of ions in the junction becomes high enough, cations will cross into the AEM and anions in the CEM. [35] In reverse bias, the dominant charge carriers will migrate in the opposite directions, that is, away from the junction. As the ions will not be replenished at the junction, it will become depleted of mobile ions, and the "off-current" will be significantly lower. In this way, the BM functions as an iontronic diode capable of rectifying ionic currents. Depending on its composition and structure, a BM diode exhibits reverse bias breakdown due to electric field-enhanced water dissociation, [36] or hysteresis upon forward-reverse switching due to excessive ion accumulation in the junction. The breakdown effect can be minimized by material choice and/or design of the BM, for example, by addition of a neutral junction [27] or by using an AEM which inhibits water splitting such as polyphosphonium (PVBPPh 3 ) (Figure 2c ). [30] Conversely, water splitting in BM diodes may be desirable, for example, to produce pH gradients. [27, 28] In such devices, hysteresis can be reduced with the use of H + /OH − as dominant charge carriers, [27] or by reducing the size of the BM junction. [28] 
Transistors
Combining two BMs results in transistors that modulate ionic currents. These transistors function similarly to electronic bipolar junction transistors, and have thus been termed ion bipolar junction transistors (IBJTs, Figure 1e ,f). [37] The three terminals of an IBJT consist of an emitter, a base, and a collector (roughly equivalent to source, gate, and drain in fieldeffect transistors). The emitter and collector have the same polarity, while the base is of opposite polarity, that is, the IBJT is either npn [29] (AEM-based emitter and collector, CEM-based base, Figure 1e ,f) or pnp. [37] An emitter-collector voltage (V EC ) is applied to electrophoretically drive ions between the emitter and collector, while an emitter-base voltage (V EB ) is used to control the emitter-collector current, I EC . The two primary operation modes for an IBJT are active and cut-off. For a npn-IBJT, the active mode is obtained when both V EC and V EB are positive. The EB junction is then forward biased, and, similar to the case for a forward-biased BM diode, cations (from the base) and anions (from the emitter) will be injected into the transistor junction. The increased ion concentration enables cations from the emitter to cross the base and, due to the positive V EC , enter the collector. V EB thus modulates the magnitude of I EC by controlling the number of ions injected from the base. In the cut-off mode, V EB is reversed, leading to depletion of ions within the transistor junction. As the concentration of anions in the base is decreased, the ionic current will decrease. When the junction is fully depleted, no charge carriers pass through the junction, and the I EC is cut off.
Iontronic Circuits and Systems
As with electronics, the combination of iontronic components into circuits and systems (Figure 3) leads to increased performance and functionality. The first such enhancement was demonstrated by adjusting the geometry of the OEIP channel. As the technology was developed largely for delivery of neurotransmitters to nerve cells and tissue (Section 6.1), a primary aim has been to mimic both synaptic spatial and temporal resolution. The spatial resolution is a fundamental aspect of OEIP delivery, with finely tuned gradients of bioactive substances possible, [12] but the temporal resolution has been a more complicated challenge. Neural synapses signal on the scale of 1-10 ms, so great effort has been made to minimize the time between voltage-on and actual delivery of neurotransmitters-even to 100s of milliseconds. OEIPs were originally based on a single lateral channel with rectangular geometry. [7] By adding a preloading "highway" branch leading to a waste system, and leaving the "exit ramp" to the target system as short as just a few 100 µm, OEIPs were able to achieve delivery of the neurotransmitter acetylcholine (ACh + ) to neuroblastoma cells (and elicit physiological response) within 200 ms of turning on the delivery voltage. [12] This branched channel was effectively a resistor network, and thus formed the first OEIP-based iontronic "circuit." More recently, the distance from the preloaded ion channel to the delivery point was further decreased by switching from lateral delivery (≈millimeters) to vertical delivery through the device's thin films (≈100 nm to 10 µm). These vertical iontronic devices have been shown to deliver ACh + within 50 ms of turning on the delivery voltage. [38] By optimization of device geometries and materials, these vertical devices are predicted to reach delivery speeds within 10 ms and on/off ratios exceeding 10 10 . [22] As with electronic components, analog iontronics can be combined to form digital circuits, and several approaches have been explored. Semi-"solid-state" (i.e., hydrogel or "soft"-state) circuits based on pnp-IBJTs and npn-IBJTs have been used to demonstrate NOT and NAND gates based [9] and modulated neurotransmitter delivery. [37] Similar circuits using BM ion diodes have been demonstrated from water-splitting and pH-regulating AND gates. [27] These circuits differ from fluidics in that they are based entirely on ion transport through ion conducting materials, rather than liquid transport through fluidic channels and junctions. Combinations of conduction through IEMs and liquid transport have also been presented, such as microfluidicbased iontronic circuits comprising fluidic channels with integrated BM diode logic (AND, OR, and NAND gates). [26] A motivation for such iontronic analog and digital circuits is to enable matrix-addressed delivery of bioactive substancesultimately a "chemical display" where each pixel independently delivers an ionic substance rather than modulated light. Standard OEIPs cannot achieve such functionality in a straightforward way, as each delivery "pixel" would require an independent channel and source electrolyte/electrode system. In contrast to the electrophoretic transport in OEIPs, controlled delivery via drug-loaded organic electronic electrodes has been demonstrated in a variety of ways over the years. In this approach, a drug or other biochemically active compound is loaded into the conducting polymer as a charge-compensating ion, and upon redox switching of the polymer, is released into the target system. [11, 16] Incorporating such controlled release into OEIP-based systems provides individual addressing of each delivery electrode and thus enables matrix functionality, as well as the "fast" vertical delivery mentioned above. [38] In this system, PEDOT:PSS was used for electrochemical drug release and was capped by a thin film of AEM polycation (qPVBC). The PSS component in the PEDOT:PSS renders it a CEM, and the full stack is thus a vertical BM (Figure 1g ). The BM configuration is designed to reduce passive leakage-a common problem with such controlled delivery electrodes-with an on-off ratio of 8.2 with 100 ms delivery/voltage pulses. This should be considered in comparison to lateral iontronic components with reported on/off ratios reaching 400. [12] In combination with a lateral OEIP channel for replenishing the ion supply, these BM-based delivery electrodes formed the addressable refillable ion diode array (ARIDA, Figure 3c ). [38] Another driving motivation for iontronics-and indeed for all bioelectronics-is to enable therapies and implants for alleviation of patients' suffering. Devices should thus be able to operate for extended periods of time-several weeks up to several years-without requiring excessive numbers of operations, for example, to replace batteries. Iontronics rely on electrochemistry at redox electrodes, thus a major limitation is the electrodes' redox capacity. This is especially evident when thin-film conducting polymer films are used. Electrode capacity can be increased by larger electrode area (or volume), but larger electrodes may limit the distance between outlet points and hinder in vivo capability. One solution to this problem is to alternate the reduction and oxidation of the electrodes, and thereby avoid full reduction (and loss of conductivity by de-doping) or full (over)oxidation (and breakdown of the π-conjugation). Alternating charging and recharging electrodes using an ion diode bridge provides a means to scale down the overall device architecture and prolong operational lifetime. [39] Note that early OEIP demonstrations used a somewhat similar multielectrode configuration to balance electrode redox, [7, 40] but this was later deemed unnecessary.
The OEIP and all subsequent IEM-based iontronics were developed primarily for transport and delivery, that is, as actuators. For fully neuronlike functionality, iontronic systems must include both chemical delivery (actuation) as well as sensing capabilities. By regulating the OEIP delivery of ACh + by an external sensor measuring the excitatory neurotransmitter Ion diode logic circuit, logic states, and input/output characteristics. c) Chemical delivery array with six independent outlets. The traces at right correspond to sequential H + delivery from each of the six outlets at separate events/times. Part (a) reproduced with permission. [39] Copyright 2014 John Wiley and Sons. Part (b) reproduced with permission. [27] Copyright 2012, Royal Society of Chemistry. Part (c) reproduced with permission. [38] Copyright 2016, the authors published by the American Association for the Advancement of Science.
glutamate (Glu), such an artificial neuron system was presented. [41] Later, the sensing function was incorporated into the delivery device by leveraging the mixed ionic and electronic conducting of PEDOT:PSS (Figure 1g ). The OEIP delivery channels terminated in PEDOT:PSS "pixels," which were also connected via gold leads to recording equipment. These 20 × 20 µm PEDOT:PSS regions allowed delivery of ions from their OEIP side, and simultaneous electrophysiological recording-of the exact region effected by the substance delivery-via the gold leads. [42] 6. Applications
In Vitro
OEIPs were originally developed to study neurological signaling in vitro via delivery of positive metal ions such as K + , Na + , and Ca 2+ . [7] The device geometries were tailored to microscope stages and petri-dish setups. These in vitro studies were based on cell depolarization upon delivery of, for example, high extracellular [K + ], which in turn activates voltage-operated Ca 2+ channels. Using standard Ca 2+ imaging techniques and human cortical neurons (HCN-2), influx of Ca 2+ could be correlated with K + delivery rate, and verified using Ca 2+ -channel blocking agents as control. Even in these early studies, the hallmark spatially localized delivery of OEIPs could be seen: the OEIP could elicit equivalent Ca 2+ response (compared to manual addition) by delivering significantly less K + to a highly localized region around the cells.
In an attempt to push the "size limit" in PEDOT:PSS-based devices, the pH-stable cationic neurotransmitter acetylcholine (ACh) was also used to trigger Ca 2+ signaling in vitro. [12] In these studies, human neuroblastoma cells (SH-SY5Y) exhibiting nicotinic ACh receptors were used. These receptors are transmembrane protein channels, which open to ion flow when activated by ACh binding. Thus, influx of Ca 2+ could be correlated with ACh delivery. This study also demonstrated the first simulations of the OEIP delivery concentration gradient (based on a diffusion model), which agreed with the observed level of cellular activation. These ACh delivery experiments were also the first demonstration of microscaled ion channels (channel outlet only 10 µm wide, on the scale of a single cell), as well as the preloading/waste system described above for faster dynamics. Subsequent studies using wider OEIP channels also verified transport of Glu, GABA, and the amino acid and excitatory neurotransmitter aspartate. [8] Moving from basic linear delivery components toward dynamic delivery of neurotransmitters is possible with nonlinear devices. Such dynamic delivery was demonstrated in vitro by a similar experiment but using a pnp-IBJT to stimulate SH-SY5Y cells by a modu lated ACh + current. Changes in intracellular Ca 2+ levels that were induced by switching V EB on/off were monitored with real-time fluorescence microscopy. [37] The diffusive nature of substance delivery from OEIPs has also been used to induce pH gradients and oscillations in the target electrolyte. [40] Oscillations in chemical concentration are a facet of all biological signaling, exemplified by neurotransmitter exocytosis exhibiting millisecond time scales, and cell proliferation with periodicities of several hours. These welldefined gradients have also been used to produce, and spatially control the assembly of amyloid structures at the nano-and micrometer scale. Amyloids are protein aggregates associated with various neurodegenerative disorders, most notably Aβ protein aggregation in Alzheimer's disease. [43] First, OEIPs were used to deliver H + and Na + to elicit amyloid-like aggregation of polymer models, [44] and later for delivery of H + to investigate actual Aβ protein aggregation [45] (Figure 4a) . These studies enabled deeper insight into the kinetics of amyloid formation, and even demonstrated previously unknown aggregation structures dependent on, for example, distance from OEIP outlet and delivery rate.
In a step toward in vivo applications targeting neurological disorders, OEIPs have also been used in ex vivo (brain slice) experiments. Specifically, as a first demonstration of a potential epilepsy treatment, the multioutlet system combined ionic delivery/electrical sensing "pixel" device described above was used to modulate and record epileptiform activity in the CA1 and CA3 regions of mouse hippocampus (postnatal day [14] [15] [16] [17] [18] . GABA was selectively delivered to three different epilepsy model systems (high K + , low Mg 2+ , and 4AP, Figure 4b ). The characteristic electrophysiological spiking of epilepsy was significantly diminished, and the effect was verified to only occur in the direct vicinity of the OEIP delivery points. [21, 42] 
In Vivo
Iontronic systems have matured over the years and developed from nonbiological demonstrations, to in vitro and ex vivo studies with cell lines and tissue, into implantable in vivo components. This development was enabled by encapsulating the open electrolytes of the original planar OEIPs in flexible tubing: the roughly square-shaped electrodes and electrolyte wells were elongated to fit in ≈1 cm-long or centimeter-long, or something similar. The first such encapsulated devices were used to stimulate the guinea pig cochlea via Glu delivery (Figure 4c ). Glu was delivered into the cochlea of sedated guinea pigs, where it bound to specific receptors on the inner hair cells, affecting auditory response. [8] This acute experiment evaluated the ability of the device to target specific cells; there are two types of hair cells (inner and outer) but only inner hair cells have the glutamate receptor. Real-time monitoring of the auditory brainstem response (ABR) verified the effect of Glu delivery compared to controls, and histology verified that Glu specifically affected the inner hair cells. More recently, a multioutlet implantable OEIP was used to demonstrate the first organic bioelectronic therapy in an awake animal. A rat model of neuropathic pain (pain related to nerve damage) in a hind leg (sciatic nerve) was used. GABA was delivered simultaneously to the four nerve-spinal cord junctions where the pain signal entered the rat's central nervous system (Figure 4d ). This local delivery of a therapeutic compound enabled significantly lower dosage than bolus injection into the spinal cord, and elicited none of the usual side effects of such an injection. [10] For localized administration of drugs to the brain, a microfluidic ion pump (µFIP) was built using a thin CEM to separate the tissue from the microfluidic reservoir. This short distance enables fast delivery using low voltages. The µFIP device shows the capability of GABA delivery in vitro and is also demonstrated in vivo by K + delivery to the cortex of a rat, causing hyperexcitability within seconds after the device was turned on. A good mechanical interface with soft brain tissue is achieved by using soft, flexible parylene sheets as both support substrate and encapsulation. [19] 
In Plantae
Following the successful utilization of iontronics in in vitro and in vivo studies-all of which were ultimately aimed at human bioelectronics-we were inspired to investigate applications in the plant kingdom. As with all biological systems, plants utilize sophisticated intra-and intercellular chemical signaling to coordinate their growth, maintain physiology, respond dynamically [45] Copyright 2016, John Wiley and Sons. Part (b) reproduced with permission. [21] Copyright 2015, John Wiley and Sons. Part (c) reproduced with permission. [8] Copyright 2009, Springer Nature. Part (d) reproduced with permission. [10] Copyright 2015, the authors, published by the American Association for the Advancement of Science under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). Part (e) reproduced. [23] Copyright 2017, National Academy of Science.
to stimuli, and mount immune responses. In addition to the familiar cell-signaling ions such as Ca 2+ , Na + , K + , etc., plants accomplish overall management of their growth and behavior using an assortment of small signaling hormones. [46] The precise understanding of which molecules are relevant, their underlying mechanisms, and the role that such mole cules play in determining exactly how plants organize and coordinate their physiological activity are areas at the forefront of plant research. Thus, development of iontronic technologies providing localized substance delivery at the tissue and cellular scale represents a major advancement in the technological capabilities for the plant research community.
To achieve effective transport of plant hormones via OEIP technology, the devices had to be specifically adapted for this application. This adaptation involved minor changes in the overall geometry, but more importantly, hormone transport required a new class of IEM material. The critical innovation was the development of the dendrolyte materials, [23] described above and in Figure 2d , which enabled transporting larger and more rigid cyclic alkanes or aromatic compounds common to the plant hormones.
In the first demonstration combining iontronics and plants, dendrolyte-based OEIPs were used to deliver biologically relevant quantities of the plant hormone auxin to the root tips of living Arabidopsis thaliana seedlings (Figure 4e ). [23] In vivo delivery to the root tissues was verified and monitored in near real time via fluorescence of auxin-sensitive reporters in transgenic seedlings-for example, fluorescent protein expression reflects the local auxin concentration. This auxin delivery was also able to induce a physiological response, in the slowing of the root growth rates.
Conclusions and Outlook
Iontronics, in the form presented in this Research News article, has developed from a novel device concept into a toolbox being studied and utilized by several groups around the world. [19, 47] The idea of leveraging electrophoretic transport is of course not new, but the combination of dense IEMs selective for small molecule transport, and organic electronic electrodes with precise electrochemistry has opened up a range of new applications and application-specific optimization. The most basic component of iontronics, the OEIP "ionic resistor", provides a means for precisely transducing electronic signals into spatiotemporally-localized fluxes of biological signaling ions (metal ions, neurotransmitters, hormones, etc.). The OEIP thus forms the basis of all biological applications of iontronics, providing precise chemical actuation that, in many aspects, mimics intercellular or synaptic signaling in biology. As such, it provides a tool not only for developing new therapeutic technologies [10] but also for elucidating biochemical pathways and basic signaling. [12] With the development of iontronic diodes and transistors (capacitors are still a work in progress), a new paradigm of functional circuit design has emerged. These diodes and transistors add the same variety and control to iontronic circuits and system as their electronic counterparts do for traditional circuitry; features such as active switching, matrix addressing, multiplexing, and digital logic, to name a few. [38, 39] In addition, these capabilities will likely enhance the ability to integrate iontronic systems with other bioelectronic tools and technologies, such as deep brain stimulators or pacemakers. Ultimately, the performance of such iontronic devices and components is only as good as the polymer material systems on which they are based. There remains a clear need for the continued development of materials that are specifically designed for use in iontronic devices and their applications.
We are now celebrating the 70th anniversary of the solidstate transistor, the 10th anniversary of the organic electronic ion pump, [7] and the 7th anniversary of the iontronic transistor. [37] In light of the amazing trajectory of electronic transistors these past decades, we can only imagine where iontronics will be in another 63 years!
